• H. Dunbar Hoskins Jr., MDThe H. Dunbar Hoskins Jr., M.D. Center for Quality Eye Care was established as a quality of care and health policy research center that advances the accessibility to and appropriateness of eye care services. The work of the Hoskins Center will help ensure that patients continue to receive high quality, evidence-based eye care within a tightening economic environment that demands increased value for services provided.

  • from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    Despite reports of visual improvement with corticosteroids, optic canal decompression, and medical therapy for indirect TON, the weight of published evidence does not demonstrate a consistent benefit for any of these interventions. In summary, no consensus exists from studie…
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    No level I evidence was available, and the existing level II and level III studies have variable primary end points, study design limitations, and only short-term follow-up data. The current literature suggests that BADM grafts represent an implantation option for lower eyel…
    Ophthalmic Technology Assessment
    from AAO OTAC Pediatric Ophthalmology/Strabismus Panel, Hoskins Center for Quality Eye Care
    Cycloplegic autorefraction is appropriate to use in pediatric population-based studies. Cycloplegic retinoscopy can be valuable in individual clinical cases to confirm the accuracy of cycloplegic autorefraction, particularly when corrected visual acuity is worse than expecte…
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    Sentinel lymph node biopsy is a promising procedure in patients with eyelid and conjunctival malignancy, and it is useful in identifying sentinel lymph nodes. However, at present, insufficient evidence exists showing that SLNB improves patient outcomes and survival. Recognit…
    Ophthalmic Technology Assessment
    from AAO OTAC Pediatric Ophthalmology/Strabismus Panel, Hoskins Center for Quality Eye Care
    Although several imaging methods demonstrated high positive and negative percent agreement with clinical diagnosis, no ophthalmic imaging method conclusively differentiated papilledema from pseudopapilledema in children because of the lack of high-quality evidence.
    Ophthalmic Technology Assessment
    from AAO OTAC Glaucoma Panel, Hoskins Center for Quality Eye Care
    Vessel density loss associated with glaucoma can be detected by OCTA. Peripapillary, macular, and choroidal vessel density parameters may complement visual field and structural OCT measurements in the diagnosis of glaucoma.
    Ophthalmic Technology Assessment
    from AAO OTAC Cornea and Anterior Segment Disorders Panel, Hoskins Center for Quality Eye Care
    The evidence reviewed shows no superiority of any single IOL implantation technique in the absence of zonular support. The various techniques seem to have equivalent visual acuity outcomes and safety profiles. Each technique has its own profile of inherent risk of postoperat…
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    Although methodological limitations and potential conflicts of interest in some studies raised concern, the existing body of literature demonstrates improvements in the signs and symptoms of MGD after IPL therapy.
    Ophthalmic Technology Assessment
    from AAO OTAC Pediatric Ophthalmology/Strabismus Panel, Hoskins Center for Quality Eye Care
    Evidence supports the efficacy and safety of both in-office and facility-based surgery for congenital NLDO. However, treating bilateral NLDO in a facility setting may be better. Because a significant percentage of children achieved resolution spontaneously before 12 months o…
    Ophthalmic Technology Assessment
    from ACR, AAD, RDS, and AAO
    Common principles and cooperation are needed to minimize the risk of ocular toxicity with hydroxychloroquine. Effective communication among prescribing physicians, patients, ophthalmologists other eye care providers optimizes hydroxychloroquine safety and efficacy.
    Clinical Statement
    from AAO OTAC Refractive Management/Intervention Panel and Hoskins Center for Quality Eye Care
    Calculation methods requiring both prerefractive surgery keratometry and manifest refraction are no longer considered the gold standard. Refractive outcomes of cataract surgery in eyes that had previous excimer laser surgery are less accurate than in eyes that did not.
    Ophthalmic Technology Assessment
    Provision of, or referral to, vision rehabilitation services is now the standard of care for all patients with vision loss. Recently, technologies for the visually impaired have proliferated, resulting in more options to help patients with any degree of vision loss.
    Clinical Statement
    from AAO PPP Committee, Hoskins Center for Quality Eye Care
    Updated evidence-based Practice Pattern® (PPP), addressing Comprehensive Adult Medical Eye Evaluation.
    Preferred Practice Pattern Guideline
    from AAO PPP Glaucoma Committee, Hoskins Center for Quality Eye Care
    Updated evidence-based Glaucoma Practice Pattern® (PPP), addressing Primary Angle-Closure Disease.
    Preferred Practice Pattern Guideline
    from AAO PPP Glaucoma Committee, Hoskins Center for Quality Eye Care
    Updated evidence-based Glaucoma Practice Pattern® (PPP), addressing Primary Open-Angle Glaucoma Suspect.
    Preferred Practice Pattern Guideline
    from AAO PPP Glaucoma Committee, Hoskins Center for Quality Eye Care
    Updated evidence-based Glaucoma Practice Pattern® (PPP), addressing Primary Open-Angle Glaucoma.
    Preferred Practice Pattern Guideline
    from Academy Board of Trustees
    The Academy recommend timely vaccination of pediatric and adult patients.
    Clinical Statement
    from AAPOS PPP Adult Strabismus Committee and AAO PPP Pediatric Ophthalmology/Strabismus Committee, Hoskins Center for Quality Eye Care
    Recommendations distilled from the PPP for Adult Strabismus
    Summary Benchmark
    from AAO OTAC Pediatric Ophthalmology/Strabismus Panel, Hoskins Center for Quality Eye Care
    No level I evidence supports the use of binocular treatment as a substitute for current therapies for amblyopia (including patching and optical treatment). Two large randomized controlled trials showed inferior performance compared with standard patching treatment.
    Ophthalmic Technology Assessment
    from AAO PPP Retina/Vitreous Committee, Hoskins Center for Quality Eye Care
    Updated evidence-based Retina/Vitreous Preferred Practice Pattern® (PPP), addressing Diabetic Retinopathy.
    Preferred Practice Pattern Guideline